Refreshing results…
Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma
UploadNeoadjuvant BRAF‐targeted therapy in regionally advanced and oligometastatic melanoma
UploadMissing publications? Search for publications with a matching author name.